
What We're Reading: Humana to Quit Exchanges; Polypharmacy in the Elderly; and FDA Shake-ups
Humana to Pull Out of 2018 Exchanges
Shortly after calling off its proposed merger with Aetna, Humana announced it would not participate in the Affordable Care Act exchanges in 2018. After analyzing membership data from the 2017 open enrollment period, “Humana is seeing further signs of an unbalanced risk pool,” the insurer stated in a
Polypharmacy On the Rise in Elderly Patients
A
Pharma Executives Keep Wary Eye on FDA's Future
President Trump’s calls to slash government regulations and speed up the FDA’s drug approval processes have put some pharmaceutical industry leaders on edge, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.